5:42 PM
 | 
Mar 06, 2012
 |  BC Extra  |  Financial News

Argos pulls IPO

Cancer immunotherapy company Argos Therapeutics Inc. (Durham, N.C.) withdrew its planned IPO citing market conditions. The company had planned to sell 5.3 million...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >